ARCHIVES

In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Zerhouni forms steering committee; Olden to retire.

August 1, 2003

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988